Search Medical Condition
Please enter condition
Please choose location from dropdown

Seminole, Florida Clinical Trials

A listing of Seminole, Florida clinical trials actively recruiting patient volunteers.

RESULTS

Found (233) clinical trials

We need volunteers 50 to 85 years of age who have early Alzheimer’s disease for a research study of an investigational drug. You or a loved one may qualify if they have early Alzheimer’s disease or memory impairment. Call 727-347-8839 today.

Phase N/A

4.35 miles

Learn More »

Meridien Research is seeking research volunteers for a clinical study of an investigational medication for low testosterone.

Phase N/A

4.35 miles

Learn More »

Meridien Research is conducting a study of an investigational medication designed to aid with these symptoms. All studies administered by a board certified physician. For more information, please call 727-347-8839

Phase N/A

4.35 miles

Learn More »

Meridien Research is seeking men and women for a research study to evaluate the effectiveness of an investigational nasal spray to reduce the number of times you get up each night to urinate.

Phase N/A

4.35 miles

Learn More »

Meridien Research is seeking men and women for a research study of ulcerative colitis.

Phase N/A

4.35 miles

Learn More »

The Equinox Study is a clinical research study that is evaluating an oral investigational medication to see if it may reduce moderate to severe pain associated with endometriosis. 

Phase

4.35 miles

Learn More »

A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)

This randomized, double-blind, placebo-controlled, parallel-group study will evaluate the efficacy and safety of crenezumab versus placebo in participants with prodromal to mild AD. Participants will be randomized 1:1 to receive either intravenous (IV) infusion of crenezumab or placebo every 4 weeks (q4w) for 100 weeks. The primary efficacy assessment will ...

Phase

4.35 miles

Learn More »

A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)

This is a 13-week, multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study to compare the efficacy and safety of 2 dose regimens of TEV-48125 (Fremanezumab) versus placebo in adult patients for the prevention of ECH.

Phase

4.35 miles

Learn More »

Heart Failure Optimization Study

This study will be conducted at thirty to sixty sites, initially in US and Europe. It will be used to observe the rate of recovery of ventricular function (EF>35%) between 90 and 180 days in newly diagnosed HF patients who were prescribed the WCD 10 days post-discharge after hospitalization for ...

Phase N/A

4.35 miles

Learn More »

A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_

The name of this trial is MissionAD2. This 24-month treatment, multicenter, double-blind, placebo-controlled, parallel group, Phase 3 study in participants with Early Alzheimer's Disease (EAD) including mild cognitive impairment (MCI) due to AD/Prodromal AD and the early stages of mild AD will be conducted to evaluate the efficacy and safety ...

Phase

4.35 miles

Learn More »